Dr. Mignon Loh – New Pediatric Hematology, Oncology, Bone Marrow Transplant and Cellular Therapy Division Chief and BTCCCR Center Director

Message from Dr. Leslie Walker-Harding, chair, University of Washington School of Medicine Department of Pediatrics; senior vice president and chief academic officer, Seattle Children’s

I am thrilled to announce that on Dec. 1 Dr. Mignon Loh will join the University of Washington (UW) School of Medicine’s Department of Pediatrics as division chief of Pediatric Hematology, Oncology, Bone Marrow Transplant and Cellular Therapy. In this role, she will provide clinical leadership at Seattle Children’s Cancer and Blood Disorders Center and research leadership as center director of the Ben Towne Center for Childhood Cancer Research (BTCCCR) at Seattle Children’s Research Institute. Loh will also serve as professor in the Department of Pediatrics at the UW School of Medicine, as well as head of the Section of Pediatric Oncology at Fred Hutchinson Cancer Research Center (Fred Hutch).

Seattle Children’s comprehensive cancer and blood disorders program is at a critical turning point. Loh will bring together UW, Seattle Children’s and the Fred Hutch to significantly accelerate our growth as a world-class destination program for pediatric patient care and research. Thanks to the work of our dedicated staff and faculty, we have already made great strides toward achieving this goal and improving the paradigm of pediatric cancer and blood disorders care worldwide. Loh’s expertise as a hematologist-oncologist and researcher, vision for the future of pediatric cancer and blood disorders care and research and leadership approach grounded in team building and collaboration will be key to taking Seattle Children’s cancer and blood disorders program to the next level.

Loh currently serves as chief of Pediatric Oncology at the Benioff Children’s Hospitals San Francisco and Oakland within the University of California, San Francisco (UCSF). At UCSF she is a Benioff Chair of Children’s Health and the Deborah and Arthur Ablin Endowed Chair in Pediatric Molecular Oncology. She is also a co-leader of the Pediatric Malignancies Program in the Helen Diller Family Comprehensive Cancer Center. In these roles, she also cares for children, adolescents and young adults with cancer, focusing on leukemia, and she mentors the next generation of cancer and blood disorders leaders, including fellows, research assistants, medical students and even patients.

On the research front, Loh has dedicated her career to making genomics discoveries in the lab that translate into new and better diagnostics and therapeutics for children, adolescents and young adults with leukemia. Her research — funded by the National Institutes of Health (NIH), the Leukemia Lymphoma Society, the St. Baldrick’s Foundation and others — also focuses on developing new approaches for studying how and why leukemia progresses in order to identify new, more precise approaches to therapy. Loh has published over 230 peer-reviewed publications in journals such as the New England Journal of Medicine, the Journal of Clinical Oncology and Blood.

In addition to her role at the Benioff Children’s Hospitals, Loh serves as the acute lymphoblastic leukemia (ALL) committee chair for the Children’s Oncology Group (COG), where she oversees the COG clinical trial portfolio for newly diagnosed and relapsed patients with ALL.

She earned her medical degree at Columbia University College of Physicians and Surgeons and did her residency in Pediatrics at Boston Children’s Hospital, as well as a fellowship in Pediatric Hematology and Oncology at the Boston Children’s Hospital/Dana Farber Cancer Institute. She also served as an instructor at Harvard Medical School. Additionally, Loh earned her bachelor’s degree in art history from Bryn Mawr College.